Highly efficient generation of isogenic pluripotent stem cell models using prime editing

Hanqin Li, Oriol Busquets, Yogendra Verma, Khaja Mohieddin Syed, Nitzan Kutnowski, Gabriella Pangilinan, Luke A. Gilbert, Helen S. Bateup, Donald C. Rio, Dirk Hockemeyer,

eLife · 2022 · 65 citations · 45 references

DOIFull text

Open access

Concepts

TL;DR

Prime editing, a Cas9‑nickase fused to reverse transcriptase guided by pegRNAs, offers a streamlined approach to introduce precise mutations in human pluripotent stem cells for disease modeling. The study aimed to benchmark prime editing against conventional methods in hPSCs and to enhance its efficiency through optimized delivery strategies. Efficiency was increased by delivering nCas9‑RT as mRNA together with chemically modified pegRNAs and nicking guides, and by stably integrating the editing machinery into the cells. Prime editing proved more efficient and precise than HDR, especially for heterozygous autosomal dominant mutations, and the mRNA‑based delivery achieved over 60 % editing, enabling correction or introduction of Parkinson’s disease mutations in hPSCs.

Abstract

The recent development of prime editing (PE) genome engineering technologies has the potential to significantly simplify the generation of human pluripotent stem cell (hPSC)-based disease models. PE is a multicomponent editing system that uses a Cas9-nickase fused to a reverse transcriptase (nCas9-RT) and an extended PE guide RNA (pegRNA). Once reverse transcribed, the pegRNA extension functions as a repair template to introduce precise designer mutations at the target site. Here, we systematically compared the editing efficiencies of PE to conventional gene editing methods in hPSCs. This analysis revealed that PE is overall more efficient and precise than homology-directed repair of site-specific nuclease-induced double-strand breaks. Specifically, PE is more effective in generating heterozygous editing events to create autosomal dominant disease-associated mutations. By stably integrating the nCas9-RT into hPSCs we achieved editing efficiencies equal to those reported for cancer cells, suggesting that the expression of the PE components, rather than cell-intrinsic features, limit PE in hPSCs. To improve the efficiency of PE in hPSCs, we optimized the delivery modalities for the PE components. Delivery of the nCas9-RT as mRNA combined with synthetically generated, chemically-modified pegRNAs and nicking guide RNAs improved editing efficiencies up to 13-fold compared with transfecting the PE components as plasmids or ribonucleoprotein particles. Finally, we demonstrated that this mRNA-based delivery approach can be used repeatedly to yield editing efficiencies exceeding 60% and to correct or introduce familial mutations causing Parkinson’s disease in hPSCs.

References

45